Srikanth Singamsetty
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$9.3MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $9.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 14, 2026 | NIH | SBIR Phase II Manufacturing and Analytical Development for JLK-247 Gene Therapy | $1.5M | Phoenix Nest Inc. |
| Aug 14, 2025 | NIH | SBIR Phase II Identification of Potential Biomarkers and Clinical Tools for use in Mucopolysaccharidosis IIIC Patients. | $1.1M | Phoenix Nest Inc. |
| Jul 1, 2024 | NIH | SBIR Phase II Identification of Potential Biomarkers and Clinical Tools for use in Mucopolysaccharidosis IIIC Patients. | $882K | Phoenix Nest Inc. |
| Sep 12, 2023 | NIH | SBIR Phase II Development of Gene Replacement Therapy for Sanfilippo Syndrome Type C | $1.5M | Phoenix Nest Inc. |
| Sep 19, 2022 | NIH | SBIR Phase II Development of gene replacement therapy for Sanfilippo Syndrome Type C | $1.5M | Phoenix Nest Inc. |
| Sep 21, 2021 | NIH | SBIR Phase II Evaluation of Clinical Outcome Assessment (COA) and Potential Biomarkers to Facilitate Interventional Trial for Mucopolysaccharidosis IIID Patients | $2.6M | Phoenix Nest Inc. |
| Sep 13, 2017 | NIH | STTR Phase I Structure-based optimization of a novel pharmacological chaperone therapy for MPSIIIC | $225K | Phoenix Nest Inc. |
Peer ranks
Federal funding#79
Awards as PI#250
Patents#273
Companies
- Phoenix Nest Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.